MZM Praxis Drs. Erlinger
- Address
- lock Available on a paid plan
MZM Praxis Drs. Erlinger - Weight Management Research Center
MZM Praxis Drs. Erlinger is a specialized medical research facility focusing on metabolic health and weight management interventions. The center contributes to advancing clinical understanding of pharmaceutical treatments for individuals struggling with excess body weight, conducting rigorous studies that evaluate novel therapeutic approaches in real-world clinical settings.
- Investigation of pharmacological interventions for overweight and obesity management
- Clinical evaluation of weight reduction therapies combined with lifestyle modifications
- Research on metabolic health optimization through integrated treatment approaches
The research center emphasizes comprehensive treatment protocols that combine pharmaceutical interventions with reduced-calorie dietary strategies and increased physical activity, reflecting current best practices in obesity medicine. Their work supports the development of evidence-based solutions for patients with overweight and obesity seeking effective, sustainable weight management outcomes.
Site Overview
Activity Indicator
Last 6 months
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in MZM Praxis Drs. Erlinger
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of the Efficacy and Safety of Cagrilintide and Semaglutide in Combination for Weight Reduction in Patients with Overweight or Obesity | Novo Nordisk A/S | Phase III | Not Recruiting | Oct 2022 | — |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.